; (bb) ulcerative colitis; (cc) thyroid disease; (dd) testicular cancer; (ee) kidney cancer; and (ff) pregnancy-induced hypertension. (II) With respect to exposure to other per- and polyfluoroalkyl substances, any disease, illness, or condition that the Secretary of Veterans Affairs, in consultation with the Administrator of the Agency for Toxic Substances and Disease Registry of the Department of Health and Human Services, determines pursuant to the study conducted under section 316 of the National Defense Authorization Act for Fiscal Year 2018 ( Public Law 115–91 ) that a positive association exists between exposure to per- and polyfluoroalkyl substances and such disease, illness, or condition. (iii) For purposes of this subparagraph— (I) any service by a veteran as a member of the reserve components for a period specified by the Secretary at a covered military installation at which individuals were exposed, or suspected to be exposed, to substances specified in clause (ii) shall be treated as active duty service, notwithstanding section 101(21) of this title